Antidepressants and testicular cancer: Cause versus association

Journal of Clinical Psychiatry

Volumn 75, Issue 3, 2014, Pages

  Andrade, Chittaranjan ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; MIRTAZAPINE; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; CANCER RISK; CONFOUNDING VARIABLE; DATA MINING; FALSE POSITIVE RESULT; HUMAN; NONHUMAN; PRIORITY JOURNAL; TESTIS CANCER; TESTIS NONSEMINOMA CANCER; CASE CONTROL STUDY; CONGENITAL MALFORMATION; DEPRESSION; DRUG SAFETY; EXPLORATORY RESEARCH; FOLLOW UP; PREGNANCY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK BENEFIT ANALYSIS; WEIGHT GAIN;

ADULT; DATA INTERPRETATION, STATISTICAL; DATA MINING; FLUOXETINE; HUMANS; MALE; META-ANALYSIS AS TOPIC; PAROXETINE; RESEARCH DESIGN; SEROTONIN UPTAKE INHIBITORS; TESTICULAR NEOPLASMS;

EID: 84898755194     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/jcp.14f09056     Document Type: Article

References (4)

1. Friedman GD, Udaltsova N, Chan J, et al. Screening pharmaceuticals for possible carcinogenic effects: initial positive results for drugs not previously screened. Cancer Causes Control. 2009;20(10):1821-1835.
2. Friedman GD, Schwalbe J, Achacoso N, et al. Antidepressants and testicular cancer. Cancer Causes Control. 2014;25(2):251-258.
3. Rhodes AE, Lin E, Streiner DL. Confronting the confounders: the meaning, detection, and treatment of confounders in research. Can J Psychiatry. 1999;44(2):175-179.
4. Andrade C. Confounding. Indian J Psychiatry. 2007;49(2):129-131.